Lexeo Therapeutics Inc (LXEO)

Finanzdaten der Lexeo Therapeutics Inc-Aktie (LXEO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	25.46%28.02	22.33	23.12	21.65	30.69
Research and Development	21.17%19.03	15.70	16.21	15.70	14.72
Depreciation and Amortization	1.37%0.07	0.07	0.07	0.07	0.06
Operating Income/Loss	25.46%-28.02	-22.33	-23.12	-21.65	-30.69
Nonoperating Income/Loss	0.75%2.15	2.14	2.20	1.37	4.59
Income/Loss From Continuing Operations Before Tax	28.08%-25.87	-20.20	-20.63	-20.28	-26.10
	28.08%-25.87	-20.20	-20.92	-20.28	-26.10
Attributable To Parent	28.08%-25.87	-20.20	-20.92	-20.28	-26.10
Basic Average Shares	5.47%85.63	81.18	-	60.98	43.57
Diluted Average Shares	5.47%85.63	81.18	-	60.98	43.57
Basic Earnings Per Share	20.00%-0.30	-0.25	-	-0.33	-0.60
Diluted Earnings Per Share	20.00%-0.30	-0.25	-	-0.33	-0.60